SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-19-306187
Filing Date
2019-12-04
Accepted
2019-12-04 16:04:03
Documents
2
Group Members
ASILOMAR ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d844167dsctoc.htm SC TO-C 24012
2 EX-99.1 d844167dex991.htm EX-99.1 80377
  Complete submission text file 0001193125-19-306187.txt   105905
Mailing Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411
Business Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-C

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Subject) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-89574 | Film No.: 191268219
SIC: 2836 Biological Products, (No Diagnostic Substances)